BrightSpec

Charlottesville, United States

Brightspec provides analytical chemistry solutions using FT-MRR spectroscopy, a new commercial technique for direct.

$18.4M raised

Dec 2022

Series C

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has BrightSpec raised?

BrightSpec has raised $18.4M in total funding. The most recent round was Series C. The last funding was announced in December 2022.

Who are BrightSpec's investors?

BrightSpec's investors include National Science Foundation, Arboretum Ventures, Genoa Ventures, Felton Group LLC, CAV Angels.

Where is BrightSpec headquartered?

BrightSpec is headquartered in Charlottesville, United States.

What does BrightSpec do?

Brightspec provides analytical chemistry solutions using FT-MRR spectroscopy, a new commercial technique for direct.

What stage is BrightSpec at?

BrightSpec is at the Series C stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 14, 2022.

MLA

"BrightSpec — Funding & Investors." VCBacked, December 14, 2022, https://www.vcbacked.co/company/brightspec. Accessed July 2, 2026.

APA

VCBacked. (2022). BrightSpec — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/brightspec

Wikipedia (cite web)

{{cite web |title=BrightSpec — Funding & Investors |url=https://www.vcbacked.co/company/brightspec |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 14, 2022.